Pronutria Adds Ex-Sanofi CEO Viehbacher to Board

Xconomy Boston — 

Cambridge, MA-based Pronutria Biosciences said today that Christopher Viehbacher, the former CEO of Sanofi, has become the newest member of its board. As part of the move, Pronutria also got an unspecified equity investment from Gurnet Point Capital, the fund Viehbacher runs. The investment, Gurnet Point’s first, closes out the $39 million Series C round Pronutria announced in May.